Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Change in Account Payables (2022 - 2023)

Bluejay Diagnostics' Change in Account Payables history spans 2 years, with the latest figure at -$254369.0 for Q4 2023.

  • For Q4 2023, Change in Account Payables changed N/A year-over-year to -$254369.0; the TTM value through Dec 2023 reached -$235760.0, down 11688.0%, while the annual FY2024 figure was -$346352.0, 46.91% down from the prior year.
  • Change in Account Payables for Q4 2023 was -$254369.0 at Bluejay Diagnostics, down from $448199.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $448199.0 in Q3 2023 and bottomed at -$520728.0 in Q2 2022.